SVP, Chief Legal Officer · Akebia Therapeutics, Inc. · Akebia Therapeutics, Inc. — Stock Option (Right to buy)
Side
A
Value
—
Shares
270.0K
Price
—
Executed
Jan 30, 2026
Disclosed
Feb 3, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 30 executedFeb 3, 2026 disclosed
AKBA · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Akebia Therapeutics, Inc. — Stock Option (Right to buy)
Ticker
AKBA
Shares
270.0K
Price per share
$0
Execution date (reported)
Jan 30, 2026
Owned after transaction
270.0K shares
Days from execution to publication
4
What this establishes
Rucci Carolyn M. filed this Form 4 reporting a grant or award of AKBA on Jan 30, 2026. It became public on Feb 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
SVP, Chief Legal Officer
Rucci Carolyn M.cik:0002107264
Issuer
Akebia Therapeutics, Inc.cik:0001517022
Revision history · 0
No field has changed since this record was first ingested.
